These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17436712)

  • 21. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities--cross-sectional study of the general population.
    Azevedo A; Bettencourt P; Almeida PB; Santos AC; Abreu-Lima C; Hense HW; Barros H
    BMC Cardiovasc Disord; 2007 Jun; 7():17. PubMed ID: 17555566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
    Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
    Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men.
    Wu T; Rifai N; Willett WC; Rimm EB
    Am J Epidemiol; 2007 Sep; 166(5):544-51. PubMed ID: 17615090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD40: a new marker in coronary heart disease.
    Blaton V
    Scand J Clin Lab Invest; 2007; 67(2):113. PubMed ID: 17365990
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnosis of coronary insufficiency and the electrocardiogram].
    Cseke Z; Matzdorff F
    Dtsch Med J; 1967 Oct; 18(20):617-23. PubMed ID: 5610709
    [No Abstract]   [Full Text] [Related]  

  • 26. [Nailfold capillaroscopy in the evaluation of Raynaud's phenomenon and undifferentiated connective tissue disease].
    Cortes S; Clemente-Coelho P
    Acta Reumatol Port; 2008; 33(2):203-9. PubMed ID: 18604184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Functional and working capacity of coronary patients].
    Barić L
    Lijec Vjesn; 1977 Jun; 99(6):390-2. PubMed ID: 895341
    [No Abstract]   [Full Text] [Related]  

  • 28. Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
    Palazzuoli A; Iovine F; Gallotta M; Nuti R
    Minerva Cardioangiol; 2007 Aug; 55(4):491-6. PubMed ID: 17653025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silent ischaemia.
    Fox KM
    Br J Clin Pract Suppl; 1988 Apr; 60():24-6. PubMed ID: 3151266
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical significance of macrophage colony stimulating factor levels in acute coronary syndrome.
    Novo G; Assennato P; Caruso M; Turturici C; Balistreri CR; Amoroso GR; Fazio G; Rotolo A; Coppola G; Hoffmann E; Caruso C; Novo S
    Minerva Cardioangiol; 2009 Feb; 57(1):7-11. PubMed ID: 19202515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing coronary heart disease in women.
    Rollini F; Mfeukeu L; Modena MG
    Maturitas; 2009 Mar; 62(3):243-7. PubMed ID: 19200669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperventilation syndrome simulating ischemic heart disease.
    King GE
    J Med Assoc Ga; 1984 Mar; 73(3):177-9. PubMed ID: 6726092
    [No Abstract]   [Full Text] [Related]  

  • 33. Apolipoprotein J and leptin levels in patients with coronary heart disease.
    Poulakou MV; Paraskevas KI; Wilson MR; Iliopoulos DC; Tsigris C; Mikhailidis DP; Perrea D
    In Vivo; 2008; 22(4):537-42. PubMed ID: 18712185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrocardiographical case. Beware of this ECG in patients presenting with cardiogenic shock.
    Tang HC; Lim ST
    Singapore Med J; 2007 Aug; 48(8):789-91; quiz 792. PubMed ID: 17657392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bradycardia in intermediate coronary syndrome.
    Azzam FG
    N Engl J Med; 1973 Sep; 289(10):537. PubMed ID: 4723578
    [No Abstract]   [Full Text] [Related]  

  • 36. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization.
    Sir JJ; Chung WY; Hwang SJ; Kang HJ; Cho YS; Koo BK; Chae IH; Choi DJ; Kim HS; Sohn DW; Kim CH; Oh BH; Park YB; Choi YS
    Int J Cardiol; 2008 Jun; 126(3):322-32. PubMed ID: 17544525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary disease.
    Battler A
    Timely Top Med Cardiovasc Dis; 2007 Nov; 11():E32. PubMed ID: 18301793
    [No Abstract]   [Full Text] [Related]  

  • 38. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease.
    Salmhofer W; Hermann J; Joch M; Kerl H; Graninger W
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome.
    Wollert KC; Kempf T; Lagerqvist B; Lindahl B; Olofsson S; Allhoff T; Peter T; Siegbahn A; Venge P; Drexler H; Wallentin L
    Circulation; 2007 Oct; 116(14):1540-8. PubMed ID: 17848615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Albumin cobalt binding ability in assessment of myocardial ischemia in patients with acute coronary syndrome].
    Kremneva LV; Kuznetsov VA
    Klin Med (Mosk); 2008; 86(4):40-4. PubMed ID: 18494285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.